Media Room

Agilent Launches InfinityLab Bio LC Full Spectrum Portfolio for Biopharma 

A range of fully biocompatible and bio-inert LC systems that enable robust, accurate bioanalysis from drug discovery and development, to QA/QC.  

InfinityLab Bio LC Portfolio

Press Briefing

Biopharma is one of the fastest-growing markets within the life sciences. Expected to generate revenue of around USD 546.6 Billion by end of 2027, that's a CAGR growth of around 10.6% between 2020 and 2027 [1]. This has led to an increased demand for improved technologies that meet the analytical needs of this industry.

Agilent proudly brings to market its complete Bio LC portfolio of fully biocompatible and bio-inert liquid chromatography (LC) systems, along with the release of several new workflow solutions including a new, biocompatible 2D-LC, Bio method development, and a new Bio Online LC solution for process monitoring and process analytical technology (PAT).


This launch complements the existing InfinityLab Bio LC solutions, such as 1260 Infinity II Bio-Inert LC System, 1260 Infinity II Bio-SEC Multi-Detector System, LC-MS based solutions with the 6545XT AdvanceBio LC/Q-TOF.

The new InfinityLab Bio LC portfolio is designed to help labs by providing a future-proof, universal LC solution that delivers InfinityLab LC performance with additional bioanalysis capability and even higher durability to harsh analytical conditions

*Additional solutions are planned for launch in late 2021.*


View press briefing presentation

Contact to request the on-demand recording of the press conference.

Product Webpage & Brochure

The InfinityLab Bio LC Solutions consist of four core systems that can be adapted to meet all your bioanalysis needs and more, such as analytical-scale purification applications with the 1260 Infinity II Bio-Inert LC. By pairing proven InfinityLab technology with biocompatible or bio-inert components, these systems enable you to meet the widest range of analytical challenges.

Visit Bio LC webpage

Download Bio LC brochure


Through this series of three infographics, discover the benefits of the InfinityLab Bio LC range for all biopharma LC users, from customers just beginning to address biopharma analysis, to experienced customers looking to expand their biopharma analysis capabilities, and to those wanting to learn how to most easily integrate an InfinityLab Bio LC into their existing laboratory environment.


Click the links below to download:


The Journey to Biopharma—Get Ready for Change

Six Continuing Benefits of Using Agilent Systems

Expand Your Scope—Integrate Agilent with Ease




[1] ReportCrux Market Research
Biopharmaceuticals Market Size, Share, Analysis & Industry Report